Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Bcl7a | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BCL7A mRNA | CTD | PMID:22079256 | Bcl7a | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Bcl7a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BCL7A mRNA | CTD | PMID:36331819 | Bcl7a | Rat | 1,1-dichloroethene | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of BCL7A mRNA | CTD | PMID:26682919 | Bcl7a | Rat | 1,2-dichloroethane | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of BCL7A mRNA | CTD | PMID:28960355 | Bcl7a | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Bcl7a (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCL7A mRNA | CTD | PMID:22206623 | Bcl7a | Rat | 17beta-estradiol | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of BCL7A mRNA | CTD | PMID:20404318 | Bcl7a | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects methylation | ISO | BCL7A (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:32653021 | Bcl7a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BCL7A mRNA | CTD | PMID:20106945 and PMID:21632981 | Bcl7a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Bcl7a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BCL7A mRNA | CTD | PMID:21570461 | Bcl7a | Rat | 2-hydroxypropanoic acid | increases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of BCL7A mRNA | CTD | PMID:30851411 | Bcl7a | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Bcl7a (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of BCL7A mRNA | CTD | PMID:20188158 | Bcl7a | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7A mRNA | CTD | PMID:28628672 | Bcl7a | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Bcl7a (Mus musculus) | 6480464 | Fenretinide results in increased expression of BCL7A mRNA | CTD | PMID:28973697 | Bcl7a | Rat | Aflatoxin B2 alpha | increases methylation | ISO | BCL7A (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of BCL7A intron | CTD | PMID:30157460 | Bcl7a | Rat | all-trans-retinoic acid | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of BCL7A mRNA | CTD | PMID:15498508 and PMID:33167477 | Bcl7a | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of BCL7A mRNA | CTD | PMID:30779732 | Bcl7a | Rat | antirheumatic drug | increases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of BCL7A mRNA | CTD | PMID:24449571 | Bcl7a | Rat | aristolochic acid A | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of BCL7A mRNA | CTD | PMID:33212167 | Bcl7a | Rat | arsenous acid | increases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BCL7A mRNA | CTD | PMID:20458559 | Bcl7a | Rat | benzo[a]pyrene | increases expression | ISO | Bcl7a (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of BCL7A mRNA | CTD | PMID:22228805 | Bcl7a | Rat | benzo[a]pyrene | affects methylation | ISO | BCL7A (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of BCL7A promoter | CTD | PMID:27901495 | Bcl7a | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | Bcl7a | Rat | benzo[e]pyrene | decreases methylation | ISO | BCL7A (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of BCL7A intron | CTD | PMID:30157460 | Bcl7a | Rat | bisphenol A | decreases methylation | ISO | Bcl7a (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of BCL7A promoter | CTD | PMID:27312807 | Bcl7a | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of BCL7A mRNA | CTD | PMID:38750585 | Bcl7a | Rat | bisphenol F | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7A mRNA | CTD | PMID:28628672 | Bcl7a | Rat | bisphenol F | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | bisphenol F results in decreased expression of BCL7A mRNA | CTD | PMID:38685157 | Bcl7a | Rat | bortezomib | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of BCL7A mRNA | CTD | PMID:20977926 | Bcl7a | Rat | cadmium dichloride | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of BCL7A mRNA | CTD | PMID:38568856 | Bcl7a | Rat | carbon nanotube | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Bcl7a | Rat | clobetasol | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | Clobetasol results in decreased expression of BCL7A mRNA | CTD | PMID:27462272 | Bcl7a | Rat | DDE | increases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BCL7A mRNA | CTD | PMID:38568856 | Bcl7a | Rat | dexamethasone | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7A mRNA | CTD | PMID:28628672 | Bcl7a | Rat | diarsenic trioxide | increases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BCL7A mRNA | CTD | PMID:20458559 | Bcl7a | Rat | diazinon | increases methylation | ISO | BCL7A (Homo sapiens) | 6480464 | Diazinon results in increased methylation of BCL7A gene | CTD | PMID:22964155 | Bcl7a | Rat | Dibutyl phosphate | affects expression | ISO | BCL7A (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of BCL7A mRNA | CTD | PMID:37042841 | Bcl7a | Rat | dorsomorphin | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Bcl7a | Rat | doxorubicin | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of BCL7A mRNA | CTD | PMID:29803840 | Bcl7a | Rat | epoxiconazole | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of BCL7A mRNA | CTD | PMID:35436446 | Bcl7a | Rat | ethanol | affects splicing | ISO | Bcl7a (Mus musculus) | 6480464 | Ethanol affects the splicing of BCL7A mRNA | CTD | PMID:30319688 | Bcl7a | Rat | folic acid | multiple interactions | ISO | Bcl7a (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCL7A mRNA | CTD | PMID:22206623 | Bcl7a | Rat | FR900359 | increases phosphorylation | ISO | BCL7A (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of BCL7A protein | CTD | PMID:37730182 | Bcl7a | Rat | indometacin | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7A mRNA | CTD | PMID:28628672 | Bcl7a | Rat | irinotecan | increases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Irinotecan metabolite results in increased expression of BCL7A mRNA and Irinotecan results in increased expression of BCL7A mRNA | CTD | PMID:15956246 | Bcl7a | Rat | methapyrilene | decreases methylation | ISO | BCL7A (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of BCL7A intron | CTD | PMID:30157460 | Bcl7a | Rat | paracetamol | affects expression | ISO | Bcl7a (Mus musculus) | 6480464 | Acetaminophen affects the expression of BCL7A mRNA | CTD | PMID:17562736 | Bcl7a | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of BCL7A mRNA | CTD | PMID:32680482 | Bcl7a | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Bcl7a (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of BCL7A mRNA | CTD | PMID:37995155 | Bcl7a | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Bcl7a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BCL7A mRNA | CTD | PMID:36331819 | Bcl7a | Rat | phenylmercury acetate | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of BCL7A mRNA | CTD | PMID:26272509 | Bcl7a | Rat | phenylmercury acetate | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL7A mRNA | CTD | PMID:27188386 | Bcl7a | Rat | potassium chromate | increases expression | ISO | BCL7A (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of BCL7A mRNA | CTD | PMID:22079256 | Bcl7a | Rat | potassium chromate | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BCL7A mRNA | CTD | PMID:22079256 | Bcl7a | Rat | rac-lactic acid | increases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of BCL7A mRNA | CTD | PMID:30851411 | Bcl7a | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of BCL7A mRNA | CTD | PMID:28374803 | Bcl7a | Rat | SB 431542 | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Bcl7a | Rat | succimer | multiple interactions | ISO | Bcl7a (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BCL7A mRNA | CTD | PMID:21641980 | Bcl7a | Rat | sunitinib | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of BCL7A mRNA | CTD | PMID:31533062 | Bcl7a | Rat | tamibarotene | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | tamibarotene results in decreased expression of BCL7A mRNA | CTD | PMID:15498508 | Bcl7a | Rat | testosterone | increases expression | ISO | Bcl7a (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of BCL7A mRNA | CTD | PMID:33848595 | Bcl7a | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of BCL7A mRNA | CTD | PMID:30723492 | Bcl7a | Rat | thiram | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Thiram results in decreased expression of BCL7A mRNA | CTD | PMID:38568856 | Bcl7a | Rat | titanium dioxide | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of BCL7A mRNA | CTD | PMID:29264374 | Bcl7a | Rat | titanium dioxide | decreases methylation | ISO | Bcl7a (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of BCL7A gene and titanium dioxide results in decreased methylation of BCL7A promoter | CTD | PMID:35295148 | Bcl7a | Rat | triphenyl phosphate | affects expression | ISO | BCL7A (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of BCL7A mRNA | CTD | PMID:37042841 | Bcl7a | Rat | triptonide | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | triptonide results in decreased expression of BCL7A mRNA | CTD | PMID:33045310 | Bcl7a | Rat | troglitazone | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | troglitazone results in decreased expression of BCL7A mRNA | CTD | PMID:28973697 | Bcl7a | Rat | tungsten | decreases expression | ISO | Bcl7a (Mus musculus) | 6480464 | Tungsten results in decreased expression of BCL7A mRNA | CTD | PMID:30912803 | Bcl7a | Rat | valproic acid | increases methylation | ISO | BCL7A (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of BCL7A gene | CTD | PMID:29154799 | Bcl7a | Rat | valproic acid | multiple interactions | ISO | BCL7A (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL7A mRNA | CTD | PMID:27188386 | Bcl7a | Rat | valproic acid | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of BCL7A mRNA | CTD | PMID:23179753 more ... | Bcl7a | Rat | valproic acid | affects expression | ISO | BCL7A (Homo sapiens) | 6480464 | Valproic Acid affects the expression of BCL7A mRNA | CTD | PMID:25979313 | Bcl7a | Rat | valproic acid | affects expression | ISO | Bcl7a (Mus musculus) | 6480464 | Valproic Acid affects the expression of BCL7A mRNA | CTD | PMID:17292431 | Bcl7a | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of BCL7A mRNA | CTD | PMID:23555832 | Bcl7a | Rat | zinc atom | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of BCL7A mRNA | CTD | PMID:18356318 | Bcl7a | Rat | zinc(0) | decreases expression | ISO | BCL7A (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of BCL7A mRNA | CTD | PMID:18356318 | |